SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...

Myriad Genetics , Inc. (NASDAQ:MYGN) stock has reached a new 52-week low, touching down at $12.16, as the company faces a challenging market environment. According to InvestingPro data, technical ...

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

Researchers at deCODE genetics have developed a groundbreaking DNA map, revealing the intricate process of genetic recombination during reproduction. This map highlights areas of DNA that undergo ...

90 Day Fiancé: Before the 90 Days star Veah Netherton is updating fans on her health after revealing a mystery illness on the season 7 tell-all. The Orlando, Florida native exclusively tells In Touch ...

La Rosa Holdings Corp. (NASDAQ: LRHC) ("La Rosa” or the "Company”), a holding company for six agent-centric, technology-integrated, cloud-based, multi-service real estate segments, today announced ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

The test employs a combination of tumour-agnostic next-generation sequencing and personalised tumour-informed droplet PCR ...

The city says the 24-inch water main break is impacting traffic from Randleman Road to Marsh Street. As President Donald ...

Cancer genetics is the study in humans and other animals of heritable gene variants that cause or confer altered risk of tumour or hematological malignancy. Individual cancer risk varies and is ...